Priorities for the COVID-19 Pandemic at the Start of 2021: Statement of the Lancet COVID-19 Commission

Jeffrey D. Sachs,Salim S. Abdool Karim,Lara B. Aknin,Joseph R. Allen,Kirsten Brosbøl,Gabriela Cuevas Barron,Peter Daszak,María Fernanda Espinosa,Ví tor Gaspar,Alejandro Gaviría,Andy Haines,Peter J. Hotez,Phoebe Koundouri,Felipe Larraín B.,Jong-Koo Lee,Muhammad Ali Pate,Paul Polman,Gabriela Ramos,K Srinath Reddy,Ismaïl Serageldin,Rajiv Shah,John Thwaites,Vaira Vīķe-Freiberga,Chen Wang,Miriam Were,Lan Xue,Ming Zhu,María Elena Bottazzi,Francesca Colombo,George Laryea-Adjei,Yanis Ben Amor,Özge Karadağ Çaman,Guillaume Lafortune,Emma Torres,Ismini Ethridge,Juliana G E Bartels
DOI: https://doi.org/10.1016/s0140-6736(21)00388-3
2021-01-01
Abstract:The Lancet COVID-19 Commission calls for three urgent actions in the COVID-19 response (our broader overview is available on our website). First, all regions with high rates of new COVID-19 cases, including the USA and the European Union (EU), should intensify measures to minimise community transmission alongside rapid deployment of COVID-19 vaccines. Second, governments should urgently and fully fund WHO and the Access to COVID-19 Tools (ACT) Accelerator,1 including COVAX. Third, the G20 countries should empower the International Monetary Fund (IMF) and multilateral development banks to increase the scale of financing and debt relief.
What problem does this paper attempt to address?